Juvenile dermatomyositis (JDM) presenting with documented involvement of an organ system other than the respiratory tract or skeletal muscle — the two organ manifestations captured by sibling codes M33.01 and M33.02.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M33.09.
Source · Editorial brief grounded in 5 cited references ↓
- Name the specific organ system involved (e.g., 'cardiac myositis,' 'GI vasculopathy,' 'calcinosis with visceral extension') — 'systemic involvement' alone will not support M33.09 over M33.00.
- Record the patient's age at symptom onset to confirm juvenile onset; adult-onset disease belongs in the M33.1x subcategory.
- Document relevant lab and diagnostic findings: CK, aldolase, LDH, myositis-specific antibodies (anti-MDA5, anti-NXP2, anti-TIF1γ), echocardiogram results, or GI imaging as appropriate to the organ involved.
- If ILD is the 'other' organ involvement, document imaging findings (HRCT pattern) and assign an additional J84.1x code; the combination captures both etiology and manifestation.
- Explicitly rule out or confirm concurrent malignancy in the record — if present, tabular hierarchy shifts the primary code to M36.0 regardless of the organ involvement documented.
Related CPT procedures
Procedure codes commonly billed with M33.09. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M33.09 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M33.00 (unspecified organ involvement) when the organ is actually named in the note — if the provider documented cardiac or GI involvement, M33.09 is required.
- Using M33.09 for respiratory or pulmonary involvement — that maps to M33.01; M33.09 is for organs other than the respiratory system and other than skeletal muscle (M33.02).
- Applying M33.09 to an adult patient with late-onset dermatomyositis — the M33.0x subcategory is reserved for juvenile-onset disease; use M33.19 for adults.
- Failing to add a secondary code for the specific organ manifestation (e.g., J84.1x for ILD, I41 for myocarditis in JDM) when payer policy requires etiology-manifestation pair coding.
- Overlooking the paraneoplastic exception — if a malignancy is documented as the underlying cause, M36.0 supersedes M33.09 per ICD-10-CM tabular hierarchy.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M33.09 applies when a patient under 18 has confirmed juvenile dermatomyositis and the clinician documents organ involvement that is neither respiratory (M33.01) nor myopathy/skeletal muscle (M33.02). Qualifying 'other' organ systems include cardiac involvement (myocarditis, arrhythmia), gastrointestinal vasculopathy, renal involvement, calcinosis with visceral extension, or central nervous system manifestations. The code sits at the end of the M33.0x subcategory as a residual specificity bucket — use it only when you can name the organ in the record; if you cannot, fall back to M33.00 (unspecified organ involvement).
The M33.0x family is age-contingent. JDM onset is by definition in childhood or adolescence; if the patient is an adult or the record is silent on age at onset, consider M33.19 (other dermatomyositis with other organ involvement) instead. Always check whether a concurrent malignancy is present — if dermatomyositis is paraneoplastic, M36.0 (dermatomyositis in neoplastic disease) takes precedence per tabular hierarchy, regardless of patient age.
Additional codes are appropriate and often required: assign J84.1x for interstitial lung disease when that is the documented 'other' organ involvement (even though respiratory involvement has its own code at M33.01, ILD coded specifically under J84 may be layered when payer policy requires etiology-manifestation pair coding). Code also any confirmed autoantibody-driven manifestation or complication that has its own billable code. Documentation must explicitly name the involved organ — generic phrases like 'systemic involvement' are insufficient to support M33.09 over M33.00.
Sibling codes
Other billable codes under M33.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What organs qualify as 'other' organ involvement under M33.09?
02Can M33.09 be used for an adult patient with dermatomyositis and cardiac involvement?
03Should I also code the specific organ manifestation separately?
04When does M36.0 override M33.09?
05What is the difference between M33.09 and M33.00?
06Does M33.09 require a 7th character extension?
07What CPT services are commonly billed alongside M33.09?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M33-/M33.09
- 03outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/code-dermatomyositis-common-rheumatology-disorder/
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M33.0
- 05pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11430821/
Mira AI Scribe
Mira's AI scribe captures patient age at symptom onset, the specific organ system involved (cardiac, GI, renal, CNS, calcinosis with visceral extension), relevant autoantibody panel results, and any imaging or biopsy findings that confirm organ involvement. That documentation prevents downcoding to M33.00 (unspecified) and closes the audit gap that arises when payers require named-organ specificity to authorize biologics or IVIG in pediatric inflammatory myopathy.
See how Mira captures M33.09 documentation